Bangkok Dusit Medical Stock Shares Outstanding
| BDULFDelisted Stock | USD 0.73 0.00 0.00% |
Bangkok Dusit Medical fundamentals help investors to digest information that contributes to Bangkok Dusit's financial success or failures. It also enables traders to predict the movement of Bangkok Pink Sheet. The fundamental analysis module provides a way to measure Bangkok Dusit's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bangkok Dusit pink sheet.
Bangkok |
Bangkok Dusit Medical Company Shares Outstanding Analysis
Bangkok Dusit's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Bangkok Dusit Medical has 0.0 of shares currently outstending. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The shares outstanding for all United States stocks is 100.0% higher than that of the company.
Bangkok Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in shares outstanding category among its peers.
Bangkok Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 13.03 B | |||
| Shares Owned By Institutions | 8.46 % | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 4.91 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 74.45 B | |||
| Gross Profit | 24.99 B | |||
| EBITDA | 17.64 B | |||
| Net Income | 7.94 B | |||
| Cash And Equivalents | 16.66 B | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 12.5 B | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | 14.56 B | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 45 | |||
| Beta | 0.43 | |||
| Market Capitalization | 13.53 B | |||
| Total Asset | 128.45 B | |||
| Retained Earnings | 28.38 B | |||
| Working Capital | (3.49 B) | |||
| Current Asset | 12.76 B | |||
| Current Liabilities | 16.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 128.45 B | |||
| Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Bangkok Pink Sheet
If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |